نتائج البحث - Arndt Weinmann

تنقيح النتائج
  1. 1
    Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step Guide

    Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step Guide حسب Lukáš Müller, Fabian Stoehr, Aline Mähringer‐Kunz, Felix Hähn, Arndt Weinmann, Roman Kloeckner

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Colony-Stimulating Factor-1

    Colony-Stimulating Factor-1 حسب Julia Menke, Kerstin Amann, Lorenzo Cavagna, Maria Blettner, Arndt Weinmann, Andreas Schwarting, Vicki Rubin Kelley

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

    Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma حسب Roman Kloeckner, Arndt Weinmann, Friederike Prinz, Daniel Pinto dos Santos, Christian Ruckes, Christoph Dueber, M. Pitton

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Hepatocellular carcinoma in patients with autoimmune hepatitis

    Hepatocellular carcinoma in patients with autoimmune hepatitis حسب Andreas Teufel, Arndt Weinmann, Catherine Centner, Anja Piendl, Ansgar W. Lohse, Peter R. Galle, Stephan Kanzler

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction

    Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction حسب Henning Schulze‐Bergkamen, Binje Fleischer, Marcus Schuchmann, Achim Weber, Arndt Weinmann, Peter H. Krammer, Peter R. Galle

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Patterns of liver injury in COVID‐19 – a German case series

    Patterns of liver injury in COVID‐19 – a German case series حسب Jörn M. Schattenberg, Christian Labenz, Marcus‐Alexander Wörns, Philipp Menge, Arndt Weinmann, Peter R. Galle, Martin F. Sprinzl

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma

    Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma حسب Dirk A. Ridder, Mario Schindeldecker, Arndt Weinmann, Kristina Berndt, Lana Louisa Urbansky, Hagen Roland Witzel, Stefan Heinrich, Wilfried Roth, Beate K. Straub

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma

    Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma حسب M. Pitton, Roman Kloeckner, Christian Ruckes, G. Wirth, Waltraud Eichhorn, Marcus A. Wörns, Arndt Weinmann, Mathias Schreckenberger, Peter R. Galle, Gerd Otto, Christoph Dueber

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network: A Pilot Study

    Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network: A Pilot Study حسب Aline Mähringer‐Kunz, Franziska Wagner, Felix Hähn, Arndt Weinmann, Sebastian Brodehl, Sebastian Schotten, Jan B. Hinrichs, Christoph Düber, Peter R. Galle, Daniel Pinto dos Santos, Roman Kloeckner

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma

    Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma حسب Arndt Weinmann, Y Alt, Sandra Koch, Carina Nelles, Christoph Düber, Hauke Lang, Gerd Otto, Tim Zimmermann, Jens U. Marquardt, Peter R. Galle, Marcus A. Wörns, Jörn M. Schattenberg

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells

    Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells حسب Martin F. Sprinzl, Florian Reisinger, Andreas S. Puschnik, Marc Ringelhan, Kerstin Ackermann, Daniel Hartmann, Matthias Schiemann, Arndt Weinmann, Peter R. Galle, Marcus Schuchmann, Helmut Friess, Gerd Otto, Mathias Heikenwälder, Ulrike Protzer

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy

    Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy حسب Marcus Schuchmann, Henning Schulze‐Bergkamen, B Fleischer, Jörn M. Schattenberg, Jürgen Siebler, Arndt Weinmann, Andreas Teufel, Marcus‐Alexander Wörns, Thomas Fischer, Siri H. Strand, Ansgar W. Lohse, Peter R. Galle

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma

    Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma حسب Matthias Pinter, Arndt Weinmann, Marcus‐Alexander Wörns, Florian Hucke, Simona Bota, Jens U. Marquardt, Dan G. Duda, Rakesh K. Jain, Peter R. Galle, Michael Trauner, Markus Peck‐Radosavljevic, Wolfgang Sieghart

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment

    Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment حسب Daniela Grimm, Jonas Lieb, Veronika Weyer, Johanna� Vollmar, Felix Darstein, Anja Lautem, Maria Hoppe‐Lotichius, Sandra Koch, Arno Schad, Jörn M. Schattenberg, Marcus A. Wörns, Arndt Weinmann, Peter R. Galle, Tim Zimmermann

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis

    Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis حسب Natascha Roehlen, Fabian Stoehr, Lukáš Müller, Hendrik Luxenburger, Simon Johannes Gairing, Marlene Reincke, Michael Schultheiß, F Berisha, Arndt Weinmann, Friedrich Foerster, Jens U. Marquardt, Robert Thimme, Peter R. Galle, Dominik Bettinger, Roman Kloeckner

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index

    Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index حسب Lukáš Müller, Felix Hähn, Aline Mähringer‐Kunz, Fabian Stoehr, Simon Johannes Gairing, Maurice Stephan Michel, Friedrich Foerster, Arndt Weinmann, Peter R. Galle, Jens Mittler, Daniel Pinto dos Santos, M. Pitton, Christoph Düber, Roman Kloeckner

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience

    Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience حسب Tiago B. R. Castro, Leonie Jochheim, Melanie Bathon, Sabrina Welland, Bernhard Scheiner, Kateryna Shmanko, Daniel Roessler, Najib Ben Khaled, Matthias Jeschke, Johannes Ludwig, Jens U. Marquardt, Arndt Weinmann, Matthias Pinter, Christian M. Lange, Arndt Vogel, Anna Saborowski

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Programmed cell death protein‐1 (<scp>PD</scp>‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world cohort

    Programmed cell death protein‐1 (<scp>PD</scp>‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world... حسب Bernhard Scheiner, Martha M. Kirstein, Florian Hucke, Fabian Finkelmeier, Kornelius Schulze, Johann von Felden, Sandra Koch, Philipp Schwabl, Jan B. Hinrichs, Fredrik Waneck, Oliver Waidmann, Thomas Reiberger, Christian Müller, Wolfgang Sieghart, Michael Trauner, Arndt Weinmann, Henning Wege, Jörg Trojan, Markus Peck‐Radosavljevic, Arndt Vogel, Matthias Pinter

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort

    Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort حسب Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, Jan Best, Thorben Fründt, Carolin Czauderna, Alica K. Beutel, Dominik Bettinger, Johannes Weiß, Tobias Meischl, Fabian Kütting, Dirk‐Thomas Waldschmidt, Pompilia Radu, Michael Schultheiß, Kai‐Henrik Peiffer, Thomas Jens Ettrich, Arndt Weinmann, Henning Wege, Marino Venerito, Jean‐François Dufour, Christian M. Lange, Matthias Pinter, Oliver Waidmann

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

    Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients حسب Sarah Berhane, Hidenori Toyoda, Toshifumi Tada, Takashi Kumada, Chiaki Kagebayashi, Shinji Satomura, Nóra Schweitzer, Arndt Vogel, Michael P. Manns, Julia Benckert, Thomas Berg, Maria Ebker, Jan Best, Alexander Dechêne, Guido Gerken, JF Schlaak, Arndt Weinmann, Marcus A. Wörns, Peter R. Galle, Winnie Yeo, Frankie Mo, Stephen L. Chan, Helen L. Reeves, Trevor F. Cox, Philip J. Johnson

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: